13 results
8-K
EX-10.1
XLO
Xilio Therapeutics Inc
28 Mar 24
Entry into a Material Definitive Agreement
7:55am
, manufacture, packaging, processing, use, distribution, marketing, labeling, promotion, sale, offer for sale, storage, import, export or disposal of any
S-3
EX-1.2
XLO
Xilio Therapeutics Inc
9 Nov 22
Shelf registration
4:15pm
, relating to the regulation of the Company and the ownership, testing, development, manufacture, packaging, processing, use, distribution, marketing
10-K
2021 FY
XLO
Xilio Therapeutics Inc
1 Mar 22
Annual report
4:07pm
Union, or EU, extensively regulate, among other things, the research, development, testing, manufacture, quality control, approval, packaging, storage … , purity, and potency of the final drug. Additionally, appropriate packaging must be selected and tested, and stability studies must be conducted
424B4
0b6sl
22 Oct 21
Prospectus supplement with pricing info
4:02pm
S-1/A
nkbtdpr83 n5
18 Oct 21
IPO registration (amended)
6:04am
S-1/A
EX-1.1
imofh7qr6a jdibfifst
18 Oct 21
IPO registration (amended)
6:04am
S-1
jjm2d
1 Oct 21
IPO registration
4:49pm
S-1
EX-10.12
y2x30sijkyd
1 Oct 21
IPO registration
4:49pm
DRS/A
i77t613solir0op6ocd
14 Sep 21
Draft registration statement (amended)
12:00am
DRS
4jmtk
24 May 21
Draft registration statement
12:00am
DRS
EX-10.11
x1q0cx6
24 May 21
Draft registration statement
12:00am
- Prev
- 1
- Next